Track topics on Twitter Track topics that are important to you
Recently added to the BioPortfolio report store, Delcath Systems, Inc. (DCTH) - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2015-04-23. This 48-page report is available in PDF from $250.
Delcath Systems, Inc. (Delcath) is a specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic liver cancers. Delcath's patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloodstream. Its clinical trial product, the Delcath Percutaneous Hepatic Perfusion System (the Delcath PHP System), also known as Hepatic Chemosaturation therapy allows physicians to deliver ultra-high doses of anti-cancer agents to the liver while controlling their systemic exposure. Delcath is headquartered in New York, the US.
Delcath Systems, Inc. (DCTH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Delcath Systems, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Delcath Systems, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Delcath Systems, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Delcath Systems, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Delcath Systems, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Delcath Systems, Inc., Medical Equipment, Deal Details 11
Delcath Systems Enters Into Agreement With Chi-Fu Trading 11
Equity Offering 12
Delcath Systems Prices Public Offering of Shares and Warrants for USD3 Million 12
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 14
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 15
Delcath Systems Completes Private Placement Of Shares For US$2 Million 16
Delcath Systems Completes Public Offering Of Units For US$23 Million 17
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 19
Delcath Systems Files Registration Statement For Public Offering Of Securities For US$100 Million 21
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 22
Delcath Systems Completes Public Offering Of Common Stock For US$33.8 Million 24
Delcath Systems Completes Public Offering Of Common Stock For US$35.28 Million 26
Delcath Systems Completes Registered Direct Offering Of Units For US$3 Million 28
Delcath Systems, Inc. - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Mar 10, 2015: Delcath Reports 2014 Fourth Quarter And Full Year Financial Results 33
Nov 05, 2014: Delcath Reports 2014 Third Quarter Results 35
Aug 06, 2014: Delcath Reports 2014 Second Quarter Results 37
May 07, 2014: Delcath Reports 2014 First Quarter Results 38
Mar 12, 2014: Delcath Reports 2013 Fourth Quarter And Full Year Results 39
Corporate Communications 41
Dec 15, 2014: Delcath Strengthens Board Of Directors With New Appointments 41
Product News 43
Mar 27, 2015: Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 43
Mar 03, 2015: Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 44
Dec 11, 2014: Delcath Adds New Centers To Global Phase 2 HCC Program 45
Clinical Trials 46
Dec 11, 2014: Delcath Adds New Centers To Global Phase 2 HCC Program 46
Other Significant Developments 47
Mar 27, 2015: Delcath Systems Announces Management Changes 47
About GlobalData 48
Contact Us 48
For more information open Delcath Systems, Inc. (DCTH) - Medical Equipment - Deals and Alliances Profile.
SKU: GDME13745DNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...